A randomised phase III trial of High Dose Palliative Radiotherapy (HDPRT) versus concurrent Chemotherapy HDPRT (C-HDPRT) in patients with good performance status, locally advanced / small volume metastatic NSCLC not suitable for radical chemo-radiotherapy